Serum 25-hydroxyvitamin D deficiency predicts poor outcomes among acute ischemic stroke patients receiving intravenous thrombolysis.

Author: Lei WEI ¹ ; Chuan CHEN ² ; Yong-Qiang DAI ¹ ; Li DING ³ ; Hai-Yan LI ¹ ; Yan-Jun LIN ⁴ ; Hao-Tian WU ¹ ; Zhen WU ¹ ; Zheng-Qi LU ¹
Author Information

1. Department of Neurology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510630, China.
2. Department of Neurosurgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510630, China.
3. Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China.
4. Department of Neurology, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong 518107, China.
Publication Type:Journal Article
MeSH: Aged; Brain Ischemia; blood; drug therapy; pathology; Female; Fibrinolytic Agents; therapeutic use; Humans; Male; Middle Aged; Retrospective Studies; Stroke; blood; drug therapy; pathology; Thrombolytic Therapy; methods; Treatment Outcome; Vitamin D; analogs & derivatives; blood
From: Chinese Medical Journal 2019;132(4):491-494
CountryChina
Language:English